Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable

Valérie Devauchelle-Pensec (1, 2) , Lea Saraux (1, 3) , Jean Marie Berthelot (4) , Michel de Bandt (5) , Divi Cornec (1, 2) , Dewi Guellec (1) , Thierry Marhadour (1) , Sandrine Jousse-Joulin (1, 2) , Maelenn Gouillou (6) , Alain Saraux (1, 2)

1 CHU - BREST - Rhumato - CHRU Brest - Service de Rhumatologie
2 LBAI - Lymphocytes B, Autoimmunité et Immunothérapies
3 L@BISEN - Laboratoire ISEN
4 Service de rhumatologie [Nantes]
5 Dep Rhumato - FORT DE FRANCE - Département de Rhumatologie
6 CIC - Brest - Centre d'Investigation Clinique

The PMR activity score (PMR-AS) includes the CRP value, which may be lacking or invalid owing to anti-IL-6 therapy. Our objective was to develop alternatives to PMR-AS that do not require CRP.

Mots clés: C-reactive protein; PMR activity score; activity score; erythrocyte sedimentation rate; polymyalgia rheumatica

Domaines: Sciences du Vivant [q-bio]

Valérie Devauchelle-Pensec, Lea Saraux, Jean Marie Berthelot, Michel de Bandt, Divi Cornec, et al.. Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable. Rheumatology, 2018, ⟨10.1093/rheumatology/kex477⟩. ⟨hal-01689404⟩